Background stories of how others approached and experienced their European Horizon funding trajectory.
The ATHENA project addresses emerging risks for the water sector in operational technology created by digitalisation. The project responds to Digital Europe call DIGITAL-ECCC-2022-CYBER-03-UPTAKE-CYBERSOLUTIONS – Uptake op Innovative Cybersecurity Solutions. The project started in September 2023 and will run until November 2026. De Vlaamse Waterweg - The Flemish Waterway participates in the project to enhance the resilience of the organisation by co-developing targeted training modules for operational technology environments.
Read the full article for detailsThe METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.